Abstract: A bioabsorbable textile for the restoration of the joint function whereas the joint is affected by partial thickness tears, small to medium full-thickness tears, large to massive full-thickness tears, acute and chronic/degenerative tears. The bioabsorbable textile may comprise polymeric yarns interconnected to form a weave or knitted configuration, wherein said bioabsorbable textile provides a combined mechanical and biological augmentation in the target joint tissue. The bioabsorbable textile may be implanted in combination with fixation tools during open, mini-open or arthroscopic repair/augmentation procedures of joint tissue tears.
Type:
Application
Filed:
November 30, 2021
Publication date:
June 2, 2022
Applicant:
Anika Therapeutics S.r.l.
Inventors:
Stefano Agnello, Edward Ahn, Matteo Centola, Steven W. Ek, Stephen J. Kennedy, Matthew M. Mannarino, Elvira Marchetto, Sonali Puri, Robert Richard, Sara Simoncioni
Abstract: A biomaterial for the treatment of spinal cord or of peripheral nerve injury, obtainable by: a) treating a hyaluronic acid derivative with a coating solution promoting Neuronal Stem Cells adhesion, branching and differentiation; b) contacting isolated Neuronal Stem Cells with the hyaluronic acid derivative obtained from step a) and culturing and expanding the absorbed cells in the presence of growth or neurotrophic factors selected from ?FGF (basic fibroblast growth factor), CNTF (ciliary neurotrophic factor), BDNF (brain derived neurotrophic factor) and GDNF (glial derived neurotrophic factor) or mixtures thereof.
Abstract: A biomaterial for the treatment of spinal cord or of peripheral nerve injury injury, obtainable by: a) treating a hyaluronic acid derivative with a coating solution promoting Neuronal Stem Cells adhesion, branching and differentiation; b) contacting isolated Neuronal Stem Cells with the hyaluronic acid derivative obtained from step a) and culturing and expanding the absorbed cells in the presence of growth or neurotrophic factors selected from ?FGF (basic fibroblast growth factor), CNTF (ciliary neurotrophic factor), BDNF (brain derived neurotrophic factor) and GDNF (glial derived neurotrophic factor) or mixtures thereof.
Abstract: Herein described is a biocompatible material comprising a polymer matrix based on hyaluronic acid derivatives and poly-?Caprolactone, the process for preparing this material, a prosthetic device constituted by this biocompatible material and a reinforcing material, the process for preparing the prosthetic device, and its use for the partial or total replacement of meniscus, and regeneration of the meniscal fibrocartilage.
Type:
Grant
Filed:
December 14, 2005
Date of Patent:
December 2, 2014
Assignees:
Anika Therapeutics S.r.l.
Inventors:
Andrea Pastorello, Luigi Ambrosio, Gennaro Tafuri, Alessandra Pavesio
Abstract: There is described a new non-woven fabric produced with the electrospinning technique, and the use thereof as new biomaterial for the biomedical and surgical field.
Type:
Grant
Filed:
July 24, 2009
Date of Patent:
October 21, 2014
Assignee:
ANIKA Therapeutics S.r.l.
Inventors:
Davide Bellini, Lanfranco Callegaro, Marie Astier, Fabio Giusti
Abstract: New biomaterials consisting of a combination of sulphated hyaluronic acid and gellan (as well as gellan that has not been associated with other polymers), to be used as a highly effective barrier to prevent post-surgical adhesions in abdominal, pelvic and, above all, spine surgery.
Type:
Grant
Filed:
May 10, 2012
Date of Patent:
May 20, 2014
Assignee:
Anika Therapeutics S.R.L.
Inventors:
Davide Bellini, Cristina Longinotti, Vittorio Crescenzi, Anna Taglienti
Abstract: New biomaterials consisting of a combination of sulphated hyaluronic acid and gellan (as well as gellan that has not been associated with other polymers), to be used as a highly effective barrier to prevent post-surgical adhesions in abdominal, pelvic and, above all, spine surgery.
Type:
Grant
Filed:
October 3, 2005
Date of Patent:
October 22, 2013
Assignee:
Anika Therapeutics S.R.L.
Inventors:
Davide Bellini, Cristina Longinotti, Vittorio Crescenzi, Anna Taglienti
Abstract: The present invention relates to novel formulations comprising lipoic acid and hyaluronic acid and/or the derivatives thereof for use in the repair of chronic ulcers, the regeneration of damaged skin, the prevention of skin aging and, when administered by the systemic route, to treat peripheral neuropathies and intoxications by chemical and/or biological agents.
Type:
Grant
Filed:
May 24, 2006
Date of Patent:
January 8, 2013
Assignee:
Anika Therapeutics S.R.L.
Inventors:
Carlo Soranzo, Doriana Senigaglia, Davide Bellini